help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Antakly, T.
Right arrow Articles by Cote, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Antakly, T.
Right arrow Articles by Cote, J. P.

Endocrinology, Vol 120, 1558-1562, Copyright © 1987 by Endocrine Society

ARTICLES

Tissue-specific dopaminergic regulation of the glucocorticoid receptor in the rat pituitary

T Antakly, S Mercille and JP Cote

The rat intermediate pituitary lobe is one of the rare tissues that is not a known glucocorticoid target and is devoid of immunoreactive glucocorticoid receptor. The intermediate lobe is poorly vascularized and receives a dopaminergic and serotonergic innervation from the hypothalamus. In previous studies we demonstrated that removal of this hypothalamic input results in the appearance of immunoreactive glucocorticoid receptor in the intermediate lobe, as demonstrated with the use of in vitro intermediate pituitary cultures and two in vivo experimental situations. We now show that this appearance of the glucocorticoid receptor is presumably due to removal of hypothalamic dopamine from the intermediate lobe cells, since in this study dopamine (or its potent agonist bromocriptine) inhibits expression of the glucocorticoid receptor in intermediate pituitary cells in primary culture, as demonstrated by [3H] dexamethasone binding and immunocytochemistry. The dopamine antagonist haloperidol blocks the inhibitory effects of the dopamine agonist. In contrast to the intermediate pituitary cells, bromocriptine does not affect glucocorticoid receptor expression in anterior pituitary cells in culture. The differential dopaminergic regulation of glucocorticoid receptor expression in the pituitary gland raises questions about possible effects of dopamine on glucocorticoid receptor levels and glucocorticoid response in other dopamine target tissues, especially in the brain.


This article has been cited by other articles:


Home page
 J EndocrinolHome page
S.-N. Lee, B. Peng, R. Desjardins, J. E Pintar, R. Day, and I. Lindberg
Strain-specific steroidal control of pituitary function
J. Endocrinol., March 1, 2007; 192(3): 515 - 525.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
P. Yan, J. Xu, Q. Li, S. Chen, G.-M. Kim, C. Y. Hsu, and X. M. Xu
Glucocorticoid Receptor Expression in the Spinal Cord after Traumatic Injury in Adult Rats
J. Neurosci., November 1, 1999; 19(21): 9355 - 9363.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
A. Saiardi and E. Borrelli
Absence of Dopaminergic Control on Melanotrophs Leads to Cushing's-Like Syndrome in Mice
Mol. Endocrinol., August 1, 1998; 12(8): 1133 - 1139.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1987 by The Endocrine Society